Abstract P1-11-21: Analysis of cognitive function in elderly HER2-positive breast cancer patients receiving either trastuzumab monotherapy or trastuzumab plus chemotherapy as a postoperative adjuvant treatment: A cognitive function sub-study of a randomized, open-label, phase 3 clinical trial (RESPECT trial)

2019 ◽  
Author(s):  
M Takahashi ◽  
M Sawaki ◽  
Y Hagiwara ◽  
Y Uemura ◽  
T Kawahara ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Cognitive Function ◽  
Breast Cancer Patients ◽  
Her2 Positive ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Trastuzumab Monotherapy ◽  
Postoperative Adjuvant Treatment ◽  
Positive Breast Cancer

Trastuzumab emtansine versus treatment of physician's choice for pretreated HER2-positive advanced breast cancer (TH3RESA): a randomised, open-label, phase 3 trial

2014 ◽  
Vol 15 (7) ◽  
pp. 689-699 ◽  
Author(s):  
Ian E Krop ◽  
Sung-Bae Kim ◽  
Antonio González-Martín ◽  
Patricia M LoRusso ◽  
Jean-Marc Ferrero ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Advanced Breast ◽  
Trastuzumab Emtansine ◽  
Her2 Positive ◽  
Open Label ◽  
Phase 3 ◽  
Open Label Phase ◽  
Versus Treatment
Sign in / Sign up

Export Citation Format

Share Document